Genmab A/S (GMAB)
27.91
-0.64
(-2.24%)
USD |
NASDAQ |
Apr 20, 16:00
27.92
0.00 (0.00%)
After-Hours: 20:00
Genmab Price : 27.91 for April 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novo Nordisk A/S | 40.46 |
| Johnson & Johnson | 230.69 |
| Ascendis Pharma A/S | 245.38 |
| Zealand Pharma A/S | 51.33 |
| Bavarian Nordic A/S | 10.33 |
Price Related Metrics
| PE Ratio | 18.03 |
| PS Ratio | 4.769 |
| Price to Book Value | 2.940 |
| Price to Free Cash Flow | 15.67 |
| Earnings Yield | 5.55% |
| Market Cap | 17.19B |
| Operating PE Ratio | 14.19 |
| Normalized PE Ratio | 16.04 |